ERNA vs. JAZZ
ERNA (Eterna Therapeutics Inc) and JAZZ (Jazz Pharmaceuticals plc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ERNA returned -64.30%/yr vs 5.37%/yr for JAZZ. Their 0.07 correlation means their historical movements had little consistent relationship.
Performance
ERNA vs. JAZZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ERNA achieves a -89.07% return, which is significantly lower than JAZZ's 48.74% return. Over the past 10 years, ERNA has underperformed JAZZ with an annualized return of -64.30%, while JAZZ has yielded a comparatively higher 5.37% annualized return.
ERNA
- 1D
- -5.48%
- 1M
- -47.69%
- 6M
- -89.25%
- YTD
- -89.07%
- 1Y
- -91.59%
- 3Y*
- -85.19%
- 5Y*
- -86.94%
- 10Y*
- -64.30%
- ALL TIME*
- -33.20%
JAZZ
- 1D
- -2.14%
- 1M
- 3.86%
- 6M
- 53.72%
- YTD
- 48.74%
- 1Y
- 118.89%
- 3Y*
- 24.98%
- 5Y*
- 8.33%
- 10Y*
- 5.37%
- ALL TIME*
- 14.95%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $350.09K | $8.77M | $15.38M | |
| $170.47M | $174.18M | $204.96M |
ERNA vs. JAZZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ERNA Eterna Therapeutics Inc | -89.07% | -72.79% | -83.62% | -44.25% | -96.14% | -6.92% | 1.82% | 12.82% | -53.68% | -50.47% |
JAZZ Jazz Pharmaceuticals plc | 48.74% | 38.04% | 0.12% | -22.79% | 25.05% | -22.81% | 10.56% | 20.43% | -7.94% | 23.50% |
Correlation
The correlation between ERNA and JAZZ is -0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.01 |
Correlation (3Y) Balances recent behavior with more history. | 0.09 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2007 | 0.07 |
The correlation between ERNA and JAZZ shifts across timeframes, from -0.01 (1 year) to 0.14 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ERNA:
$1.03M
JAZZ:
$15.88B
ERNA:
-$23.80
JAZZ:
$0.47
ERNA:
0.38
JAZZ:
3.69
ERNA:
$0.00
JAZZ:
$4.44B
ERNA:
-$69.00K
JAZZ:
$2.97B
ERNA:
-$11.25M
JAZZ:
$336.83M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ERNA vs. JAZZ — Risk / Return Rank
ERNA
JAZZ
ERNA vs. JAZZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ERNA | JAZZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.84 | ||
| Sortino ratioReturn per unit of downside risk | -6.29 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.60 | -0.78 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 10.62 | -11.62 |
| Martin ratioReturn relative to average drawdown | -1.47 | 26.47 | -27.95 |
Loading charts...
Drawdowns
ERNA vs. JAZZ - Drawdown Comparison
The maximum ERNA drawdown since its inception was -100.00%, roughly equal to the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for ERNA and JAZZ.
Loading charts...
Drawdown Indicators
| ERNA | JAZZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -96.90% | -3.10% |
Max Drawdown (1Y)Largest decline over 1 year | -93.02% | -11.42% | -81.60% |
Max Drawdown (3Y)Largest decline over 3 years | -99.70% | -32.71% | -66.99% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -42.03% | -57.97% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -52.10% | -47.90% |
Current DrawdownCurrent decline from peak | -100.00% | -2.14% | -97.86% |
Average DrawdownAverage peak-to-trough decline | -86.20% | -27.20% | -59.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 62.71% | 4.57% | +58.14% |
Volatility
ERNA vs. JAZZ - Volatility Comparison
Eterna Therapeutics Inc (ERNA) has a higher volatility of 35.09% compared to Jazz Pharmaceuticals plc (JAZZ) at 7.70%. This indicates that ERNA's price experiences larger fluctuations and is considered to be riskier than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ERNA | JAZZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 35.09% | 7.70% | +27.39% |
Volatility (6M)Calculated over the trailing 6-month period | 132.84% | 22.87% | +109.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 154.51% | 37.42% | +117.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.04% | 31.96% | +82.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 149.29% | 32.70% | +116.59% |
Dividends
ERNA vs. JAZZ - Dividend Comparison
Neither ERNA nor JAZZ has paid dividends to shareholders.
Financials
ERNA vs. JAZZ - Financials Comparison
This section allows you to compare key financial metrics between Eterna Therapeutics Inc and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ERNA and JAZZ have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERNA has higher volatility (35.09%) compared to JAZZ (7.70%). In terms of maximum drawdown, ERNA dropped -100.00% vs JAZZ's -96.90%.
JAZZ currently has the higher Sharpe Ratio (3.24 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ERNA and JAZZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer